blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3806877

EP3806877 - PROBIOTIC COMPOSITIONS AND USES THEREOF [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  29.06.2023
Database last updated on 11.09.2024
FormerRequest for examination was made
Status updated on  19.03.2021
FormerThe international publication has been made
Status updated on  27.12.2019
Formerunknown
Status updated on  08.07.2019
Most recent event   Tooltip02.04.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
PROBI AB
Ideongatan 1A
223 70 Lund / SE
[2021/16]
Inventor(s)01 / LARSSON, Niklas
Probi AB
Ideongatan 1A
SE-223 70 Lund / SE
02 / LAZOU AHRÉN, Irini
Probi AB
Ideongatan 1A
SE-223 70 Lund / SE
 [2021/16]
Representative(s)Potter Clarkson
Chapel Quarter
Mount Street
Nottingham NG1 6HQ / GB
[N/P]
Former [2021/16]Potter Clarkson
The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
Application number, filing date19733982.313.06.2019
[2021/16]
WO2019EP65588
Priority number, dateGB2018000994718.06.2018         Original published format: GB 201809947
GB2019000538916.04.2019         Original published format: GB 201905389
[2021/16]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019243168
Date:26.12.2019
Language:EN
[2019/52]
Type: A1 Application with search report 
No.:EP3806877
Date:21.04.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 26.12.2019 takes the place of the publication of the European patent application.
[2021/16]
Search report(s)International search report - published on:EP26.12.2019
ClassificationIPC:A61K35/747, A61P19/10
[2021/16]
CPC:
A61K35/747 (EP,KR,US); A61K31/59 (KR); A61K31/593 (US);
A61P19/10 (EP,KR,US); C12N1/20 (KR); C12R2001/225 (KR)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/16]
TitleGerman:PROBIOTISCHE ZUSAMMENSETZUNGEN UND VERWENDUNGEN DAFÜR[2021/16]
English:PROBIOTIC COMPOSITIONS AND USES THEREOF[2021/16]
French:COMPOSITIONS PROBIOTIQUES ET LEURS UTILISATIONS[2021/16]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase15.01.2021National basic fee paid 
15.01.2021Designation fee(s) paid 
15.01.2021Examination fee paid 
Examination procedure15.01.2021Examination requested  [2021/16]
15.01.2021Date on which the examining division has become responsible
29.07.2021Amendment by applicant (claims and/or description)
28.06.2023Despatch of a communication from the examining division (Time limit: M06)
18.12.2023Reply to a communication from the examining division
Fees paidRenewal fee
09.06.2021Renewal fee patent year 03
31.03.2022Renewal fee patent year 04
21.06.2023Renewal fee patent year 05
31.03.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XDI]WO2014163568  (PROBI AB [SE]) [XD] 1-3,6,8,10-15,17-20 * page 4, lines 1-6; examples 1-34; claims 1-9; table 2 * [I] 1-20;
 [A]  - SHEN-SHIH CHIANG ET AL, "Antiosteoporotic Effects of Lactobacillus -Fermented Soy Skim Milk on Bone Mineral Density and the Microstructure of Femoral Bone in Ovariectomized Mice", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, US, (20110727), vol. 59, no. 14, doi:10.1021/jf2013716, ISSN 0021-8561, pages 7734 - 7742, XP055489729 [A] 1-20 * abstract;; figures 2-3 *

DOI:   http://dx.doi.org/10.1021/jf2013716
 [A]  - CHIANG S S ET AL, "Effect of bioactive compounds in lactobacilli-fermented soy skim milk on femoral bone microstructure of aging mice", JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, WILEY & SONS, CHICHESTER, GB, (20120101), vol. 92, no. 2, doi:10.1002/JSFA.4579, ISSN 0022-5142, pages 328 - 335, XP002761259 [A] 1-20 * abstract;; figures 1-3 *

DOI:   http://dx.doi.org/10.1002/jsfa.4579
 [X]  - OHLSSON CLAES ET AL, "Probiotics Protect Mice from Ovariectomy-Induced Cortical Bone Loss", PLOS ONE, PUBLIC LIBRARY OF SCIENCE, US, (20140301), vol. 9, no. 3, ISSN 1932-6203, pages 1 - 8, XP002761260 [X] 1,13-15,17-20 * abstract;; table 2 *
 [A]  - FRASER L. COLLINS ET AL, "The Potential of Probiotics as a Therapy for Osteoporosis", MICROBIOLOGY SPECTRUM, (20170801), vol. 5, no. 4, doi:10.1128/microbiolspec.BAD-0015-2016, XP055625516 [A] 1-20 * abstract *

DOI:   http://dx.doi.org/10.1128/microbiolspec.BAD-0015-2016
by applicantWO03026687
 US8007777
 US8540980
 WO2014163568
 WO2016003870
 WO2017060477
 WO2018224509
    - Lancet, (20100515), vol. 375, no. 9727, pages 1729 - 36
    - MCDONNELL et al., Ann Biomed Eng, (20070000), vol. 35, no. 2, pages 170 - 189
    - MILZPUTZ, "Quantitative morphology of the subchondral plate of the tibial plateau", J Anat, (19940000), vol. 185, pages 103 - 110
    - HILL et al., Nat Rev Gastroenterol Hepatol, (20140000), vol. 11, no. 8, pages 506 - 514
    - ARIJMAND, Sci Rep, (20190000), vol. 8, no. 1, page 11478
    - Remington: The Science and Practice of Pharmacy, Mack Publishing Company, (19950000), vol. 1 & 2
    - ELLEKILDE et al., Sci Rep, (20140000), vol. 4, page 5922
    - REIKVAM et al., PLoS One, (20110000), vol. 6, no. 3, page e17996
    - VAN 'T HOF, "Analysis of bone architecture in rodents using microcomputed tomography", Methods Mol Biol, (20120000), vol. 816, pages 461 - 476
    - BOUXSEIN et al., "Guidelines for assessment of bone microstructure in rodents using micro-computed tomography", J Bone Miner Res, (20100000), vol. 25, pages 1468 - 1486
    - CAMPBELLSOPHOCLEOUS, "Quantitative analysis of bone structure by micro-computed tomography", BoneKEy Reports, (20140000), vol. 3, page 564
    - SOPHOCLEOUS et al., "The type 2 cannabinoid receptor regulates susceptibility to osteoarthritis in mice", Osteoarthr Cartil, (20150000), vol. 23, pages 1585 - 1594
 GB20170008932
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.